Why a Vision Care Company Belongs in Our Portfolio

Today is a big day for RAD Intel, and I'm proud of what our team has accomplished to get us here.

We started as an agency, building technology to help brands understand their audiences and grow. We earned the business of Fortune 1000 companies and put our platform to work in real campaigns. Today, our portfolio has more than 60 enterprise contracts, and sales contracts grew 10x from 2025 to 2026, driven by our acquisition of AV Communications.

Those milestones represent years of work from people who believed we could build something much bigger than an agency. And today, we get to show you where that work is taking us.

We're thrilled to introduce Altivera Vision.

With Altivera, we're bringing our marketing intelligence technology into vision care. Working alongside Dr. Jeffery Machat and his team, we plan to help ophthalmology practices grow, strengthen the business support available to physicians, and connect more people with the care they need.

When we started building RAD Intel as a holding company, we saw an opportunity to take technology we’ve developed and applied in one industry, bring it into another, and work with experienced leaders who know how to put it to use.

I'm especially proud of the people who made this possible. Our team has spent years building the technology and the business behind it. Our investors have supported our ambition to keep growing. Altivera is another opportunity to deliver on that ambition while putting what we've built to work in an industry that touches people's lives in a very personal way.

And we're just getting started.

Here's your first look at Altivera Vision.

Why Vision Care Makes Sense for RAD Intel

When I look at a business, I want to understand what's standing between the team and its next stage of growth. Sometimes, the opportunity is already walking through the door.

Someone considering LASIK sees an ad, researches a practice, and requests information. They're interested. Now they need answers, a conversation, and a physician who can help them understand their options.

That's where several teams come into the picture. Marketing. Scheduling. Patient coordination. Clinical care. Each has a job to do, and the handoffs between them can shape the entire experience. If an inquiry sits unanswered or someone never gets the information they need, all the work that brought them there can go nowhere.

You paid to get someone's attention, then lost them in the handoff. If you work in marketing, you probably just winced.

Altivera is being built to help practices connect those pieces, understand where people disengage, and make better use of the resources they already have. Physicians lead clinical decisions. Our focus is strengthening the business around them.

You Want This Experience in the Room

Dr. Jeffery Machat, Altivera's President and Chief Medical Officer, has spent more than 35 years in vision care. He founded TLC Laser Eye Centers, has performed more than 110,000 LASIK procedures, and has helped develop approximately 150 clinics across North America and Europe. He's built in this industry. He knows the questions to ask.

That gives us a much stronger place to start. We can bring our capabilities to specific challenges, guided by someone who understands the patients, the physicians, and the realities of running practices.

I love working with people who know their business inside and out and have the ambition to take it further.

How Altivera Fits RAD Intel's AIBO Strategy

RAD Intel's Artificial Intelligence Buyout, or AIBO, strategy connects established business expertise with shared intelligence, technology, and growth capabilities. Altivera puts that approach to work in vision care.

For RAD Intel, that creates another way to commercialize the intelligence we've built. For practices, it means access to capabilities they may struggle to develop alone, with experienced vision care leadership helping direct the work.

The ambition is straightforward. Help a practice understand what's holding back growth. Make a change. Measure whether it helped. Take what works and see where else it can be useful.

A better follow-up process at one location could give another team a starting point. A clearer understanding of prospective patients could improve the next campaign. Over time, those lessons can help us build a stronger business.

We're going to keep building on what works, one company at a time.

Our investors have backed a vision for what RAD Intel can become. We owe them execution. Altivera gives us another business in which to do that work, alongside people with the experience to help us get it right.

We're building the portfolio we said we would build. Learn more about Altivera Vision.

What Marketers Should Know Now

• Marketers are losing track of leads after the handoff. A November 10 report from Invoca found that 56% of surveyed marketers couldn't track leads once they reached a dealer, franchise, or local branch. The same research found that 74% of marketers using AI agents lacked visibility into whether those interactions ultimately led to sales. Marketing teams can generate plenty of interest and still have little visibility into what happens after a lead is passed along. Read Invoca's research.

• Healthcare scheduling is becoming a new opportunity for AI. On October 28, Zocdoc opened its healthcare access infrastructure to AI agents, allowing them to help connect patients with appointments through supported integrations. The move shows how AI could change the process between researching care and booking a visit, particularly as patients begin using AI assistants to navigate healthcare options. Read Fierce Healthcare's coverage.

• AI expertise is becoming part of acquisition strategy. On November 5, EXL announced its acquisition of Aimpoint Digital, a data and AI consulting firm. The deal combines EXL's industry experience and operational scale with Aimpoint's engineering and AI platform capabilities. It's another example of companies using acquisitions to bring specialized technical expertise into established businesses. Read EXL's announcement.

• Investors are putting AI to work inside established companies. Private equity firm Aldaron closed its debut fund with more than $950 million in commitments and a strategy focused on improving acquired businesses through AI. At one portfolio company, AI-assisted research reportedly increased the number of potential asset opportunities identified each week. The approach reflects growing investor interest in using AI to improve how existing businesses operate and grow. Read The Wall Street Journal’s reporting on the firm’s launch.